Fullerton Fund Management’s ResMed RMD Stock Holding History

Fullerton Fund Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,010	Closed	-$261K	–	116
2025 Q2	$261K	Sell	1,010 -294	-23%	-$70.1K	0.01%	88
2025 Q1	$292K	Buy	+1,304	New	+$304K	0.02%	100
2024 Q2	–	Sell	-1,319	Closed	-$261K	–	177
2024 Q1	$261K	Buy	+1,319	New	+$242K	0.01%	151

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Fullerton Fund Management's RMD Position: Q3 2025 in Review

Fullerton Fund Management sold out of ResMed (RMD) in Q3 2025, closing a stake of 1,010 shares — an estimated $261K sold.

Fullerton Fund Management first reported a position in RMD in Q1 2024 and held it in 3 quarters. The position peaked at $292K in Q1 2025. 950 funds tracked by Wall St. Rank hold RMD as of Q3 2025.

Fullerton Fund Management reported no remaining ResMed position as of Q3 2025 after selling out during the quarter.
Fullerton Fund Management sold 1,010 ResMed shares in Q3 2025, an estimated $261K.
Fullerton Fund Management first reported a position in ResMed in Q1 2024 and held it in 3 quarters.
Fullerton Fund Management's ResMed position peaked at $292K in Q1 2025.
950 funds tracked by Wall St. Rank held ResMed as of Q3 2025.

Based on Fullerton Fund Management's 13F filing for Q3 2025, filed 14 Nov 2025.